Five years survival of women with various breast cancer stages. Retrospective research

DJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, DJURAEV Farrukh Mirjalolovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2025-yil

Annotatsiya

Introduction: Analysis of sample allows estimating reserves of the clinical control of a cancer, for example - research of five-year survival depending from a stage of the tumor growth motivates development of practice of early diagnostics (of screening). Aim: To estimate the probability of the five-year survival of patients with MC in sample them from clinic stream of TCB of RSSPMCO&R depending on a stage of tumor growth during 2017-2022 - in the conditions of absence of the developed practice of MC screening. Material and methods: A casual selection with formatting of the sample from a stream of patients with MC who were treated in period from 01.07.2017 to 31.12.2022; an estimation of their probability of five year survival. Control date (CD) supervision - 01.04.2023 Results: The women who were taken on the dispensary account with diagnosis of MC for the first time and had been treating in clinic of TCB of RSSPMCO&R constituted about three quarters (76,0%) of the stream of patients which was formed by this clinic. The basic fraction of this stream (45,4 %) was constituted by patients with II stage of MС. The fractions of patients with III-IV stages constituted accordingly 21,8%, 14,9% and these were above statistically (p<0,05) than fraction of patients with 0-I stages (9,1%). The fraction of patients without detected stage of MC (8,9%) was statistically identical to fraction of patients with 0-I stages. During first three years after the beginning of special treatment the survival rate at patients of sample was above (p<0,05) than the same rate at the population level (79,5% (CI95%=77,9÷81,0)). Five-year survival of patients in clinical sample constituted 82,1% (CI95%=78,6÷85,6), and this was statistically above (p>0.05) than same coefficient at population level. At stages 0-I, II, III and IV of MC these coefficients of survival were accordingly 93,0, 87,5, 77,7 and 65,5%, and at patients without detected stage of MC - 78,4%. Conclusion: The five-year survival of patients with 0-I-II-nd stages of MC in clinical sample is statistically equal to survival rate on the population level in socio-economically developed countries of the world. The five-year survival at population level in Tashkent city is significantly limited by a high fraction of patients with III-IV-th stages of MC and fraction of patients without detected stage of MC. This is related with absence of the developed practice of screening in a city.

Maqola ma’lumotlari
MualliflarDJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, DJURAEV Farrukh Mirjalolovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
NashriyotТошкент давлат стоматалогия институти, , «Expert Lawyers» MЧЖ
ISSN2181-9300
Nashr sanasi2025-09-08
Jild10
Son3/2
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-27

Maqolaning asl sahifasi

Kalit so‘zlar

рак молочной железы, специальное лечение, выживаемость, mammary cancer; stages of cancer; special treatment; survival rate, sut bezi saratoni, maxsus davolash, tirik qolish

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APADJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, & DJURAEV Farrukh Mirjalolovich (2025). FIVE YEARS SURVIVAL OF WOMEN WITH VARIOUS BREAST CANCER STAGES. RETROSPECTIVE RESEARCH. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 10(3/2). https://tadqiqot.uz/index.php/biomedicine/article/view/12283
GOST (OAK)DJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, DJURAEV Farrukh Mirjalolovich FIVE YEARS SURVIVAL OF WOMEN WITH VARIOUS BREAST CANCER STAGES. RETROSPECTIVE RESEARCH // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. – 2025. – T. 10, № 3/2.
MLADJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, and DJURAEV Farrukh Mirjalolovich. “FIVE YEARS SURVIVAL OF WOMEN WITH VARIOUS BREAST CANCER STAGES. RETROSPECTIVE RESEARCH.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 10(3/2), 2025. https://tadqiqot.uz/index.php/biomedicine/article/view/12283
ChicagoDJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, and DJURAEV Farrukh Mirjalolovich. “FIVE YEARS SURVIVAL OF WOMEN WITH VARIOUS BREAST CANCER STAGES. RETROSPECTIVE RESEARCH.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 10(3/2) (2025). https://tadqiqot.uz/index.php/biomedicine/article/view/12283
HarvardDJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, and DJURAEV Farrukh Mirjalolovich (2025) ‘FIVE YEARS SURVIVAL OF WOMEN WITH VARIOUS BREAST CANCER STAGES. RETROSPECTIVE RESEARCH’, Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 10(3/2). https://tadqiqot.uz/index.php/biomedicine/article/view/12283
BibTeX
@article{djuraevmirjaloldehkanovich2025,
  title = {FIVE YEARS SURVIVAL OF WOMEN WITH VARIOUS BREAST CANCER STAGES. RETROSPECTIVE RESEARCH},
  author = {DJURAEV Mirjalol Dehkanovich and RIZAEV Jasur Alimdjanovich and DJURAEV Farrukh Mirjalolovich},
  journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
  year = {2025},
  volume = {10},
  number = {3/2},
  url = {https://tadqiqot.uz/index.php/biomedicine/article/view/12283}
}

Boshqa maqola uchun iqtibos tayyorlash

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar · 2025-yil arxivi

DJURAEV Mirjalol Dehkanovich — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari